Showing results (1-10 of 201) with videos related to
Sort By:
Pageof 21
Journal of Neuro-Oncology|July 1, 1989
Calmodulin content in human central nervous system tumorsA J Bridges, A K HoNeuroscience Letters|July 19, 1988
Calmodulin content in human prolactin-secreting pituitary adenoma: an inverse relationship to serum prolactin levelsA J Bridges, A K HoBiochemical Society Transactions|March 25, 2005
Therapeutic challenges of kinase and phosphatase inhibition and use in anti-diabetic strategyA J BridgesCurrent Medicinal Chemistry|September 25, 1999
The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinasesA J BridgesJournal of Biomaterials Science. Polymer Edition|January 1, 1995
Rheumatic disorders in patients with silicone implants: a critical reviewA J BridgesSeminars in Arthritis and Rheumatism|August 1, 1994
Autoantibodies in patients with silicone implantsA J BridgesCurrent Topics in Microbiology and Immunology|January 1, 1996
Clinical and laboratory features of patients with scleroderma and silicone implantsT Field, A J BridgesCurrent Opinion in Biotechnology|December 1, 1995
Inhibitors of protein tyrosine kinasesD W Fry, A J BridgesArthritis and Rheumatism|May 1, 1992
Acute iritis associated with primary Sjögren's syndrome and high-titer anti-SS-A/Ro and anti-SS-B/La antibodies. Treatment with combination immunosuppressive therapyA J Bridges, R P BurnsAngiology|July 1, 1993
Tissue plasminogen activator treatment of digital thrombosis in severe Raynaud's phenomenon--a case reportA J Bridges, D P SpadonePageof 21